Skip to Content


In the US, Raloxifene (raloxifene systemic) is a member of the following drug classes: hormones/antineoplastics, selective estrogen receptor modulators and is used to treat Breast Cancer - Prevention, Osteoporosis and Prevention of Osteoporosis.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Selective estrogen receptor modulator (SERM)

Chemical Name

Metanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]tien-3-yl]-[4-[2-(1-piperidinyl)etoxy]phenyl]-

Foreign Names

  • Raloxifenum (Latin)
  • Raloxifen (German)
  • Raloxifène (French)
  • Raloxifeno (Spanish)

Generic Names

  • Raloxifene (OS: BAN)
  • Raloxifène (OS: DCF)
  • Keoxifene (IS)
  • LY 139481 (Lilly) (IS)
  • Raloxifene Hydrochloride (OS: BANM, USAN, JAN)
  • Keoxifene Hydrochloride (IS)
  • LY 156758 (Lilly) (IS)
  • Raloxifène (chlorhydrate de) (PH: Ph. Eur. 9)
  • Raloxifene hydrochloride (PH: Ph. Eur. 9)
  • Raloxifene Hydrochloride (PH: BP 2018, USP 41)
  • Raloxifenhydrochlorid (PH: Ph. Eur. 9)
  • Raloxifeni hydrochloridum (PH: Ph. Eur. 9)

Brand Names


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.